EP2935461B1 - Prosthetic device - Google Patents

Prosthetic device Download PDF

Info

Publication number
EP2935461B1
EP2935461B1 EP13818212.6A EP13818212A EP2935461B1 EP 2935461 B1 EP2935461 B1 EP 2935461B1 EP 13818212 A EP13818212 A EP 13818212A EP 2935461 B1 EP2935461 B1 EP 2935461B1
Authority
EP
European Patent Office
Prior art keywords
polymer
prosthetic device
paek
nitride
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Not-in-force
Application number
EP13818212.6A
Other languages
German (de)
French (fr)
Other versions
EP2935461A1 (en
Inventor
Mohammad Jamal El-Hibri
David B. Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Solvay Specialty Polymers USA LLC
Original Assignee
Solvay Specialty Polymers USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Specialty Polymers USA LLC filed Critical Solvay Specialty Polymers USA LLC
Priority to EP13818212.6A priority Critical patent/EP2935461B1/en
Publication of EP2935461A1 publication Critical patent/EP2935461A1/en
Application granted granted Critical
Publication of EP2935461B1 publication Critical patent/EP2935461B1/en
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/56Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B17/58Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
    • A61B17/68Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
    • A61B17/80Cortical plates, i.e. bone plates; Instruments for holding or positioning cortical plates, or for compressing bones attached to cortical plates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/56Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B17/58Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
    • A61B17/68Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
    • A61B17/84Fasteners therefor or fasteners being internal fixation devices
    • A61B17/86Pins or screws or threaded wires; nuts therefor
    • A61B17/866Material or manufacture
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/443Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with carbon fillers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/34Silicon-containing compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/38Boron-containing compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K7/00Use of ingredients characterised by shape
    • C08K7/02Fibres or whiskers
    • C08K7/04Fibres or whiskers inorganic
    • C08K7/06Elements
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K7/00Use of ingredients characterised by shape
    • C08K7/02Fibres or whiskers
    • C08K7/04Fibres or whiskers inorganic
    • C08K7/14Glass
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2/2875Skull or cranium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001Designing or manufacturing processes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2650/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G2650/28Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
    • C08G2650/38Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type containing oxygen in addition to the ether group
    • C08G2650/40Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type containing oxygen in addition to the ether group containing ketone groups, e.g. polyarylethylketones, PEEK or PEK
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/38Boron-containing compounds
    • C08K2003/382Boron-containing compounds and nitrogen

Definitions

  • the present invention is related to a prosthetic device comprising at least one structural part made of a poly(aryletherketone) polymer composition wherein said poly(aryletherketone) polymer composition is characterized by having improved mechanical properties, in particular having an excellent balance of stiffness and ductility, and thus are providing structural parts to be thinner and maintaining high stiffness.
  • prosthetic devices Due both to demographic change and to developments in medical science, the number of surgical procedures involving prosthesis implantation is rising rapidly.
  • the more obvious examples of prosthetic devices are hip or knee replacements and false teeth.
  • Other less well-known examples are stents, heart valves, bone screws and plates and spinal fixators.
  • Prosthesis must be tolerated by the patient and not altered in time. Materials that may be suitable for each type of prosthesis are subjected to precise specifications. Indeed, if the prosthesis is a dental implant or a hip replacement the specifications will be very different.
  • the most important requirements are mechanical properties similar to those of bone to allow the transfer constraints between bone and prosthesis, chemical resistance to corrosion, chemical inertia in relation to the environment and biocompatibility. These properties must be controlled to maintain the integrity of used materials.
  • the human body is an aggressive and corrosive environment mainly because of concentrations of chloride ions (113 mEq/l in blood plasma and 117 mEq/l in the interstitial fluid, which is sufficient to corrode metallic materials) and dissolved oxygen.
  • biocompatibility is defined by the Dorland's Medical Dictionnary as the quality of not having toxic or injurious effects on biological systems. This encompasses both the material and host responses to an implant.
  • the host response to an implant can be highly complex and is often linked to the material response. It is also dependent on the anatomical position of the implant. For a material to be biocompatible, it should not elicit any adverse host reactions to its presence. Inflammation and encapsulation phenomena may occur when the prosthesis suffer from low biocompatibility.
  • prosthetic devices are made of inorganic (metal, alloys, ceramic and glass) and/or polymeric materials.
  • metals have the drawback that they are too stiff, and preventing the bone from bearing as much weight and causing the surrounding bone to disappear.
  • a prosthetic dental device is made of a thermoplastic polymer including a poly(aryl ketone), such as poly(ether ether ketone) (PEEK), polymethylmethacrylate (PMMA), poly(aryl ether ketone) (PAEK), poly(ether ketone) (PEK), poly(ether ketone ether ketone ketone) (PEKEKK), poly(ether ketone ketone) (PEKK), and/or polyetherimide (PEI), polysulfone (PSU), and polyphenylsulfone (PPSU).
  • a poly(aryl ketone) such as poly(ether ether ketone) (PEEK), polymethylmethacrylate (PMMA), poly(aryl ether ketone) (PAEK), poly(ether ketone) (PEK), poly(ether ketone ether ketone ketone) (PEKEKK), poly(ether ketone ketone) (PEKK), and/or polyetherimide (PEI),
  • PAEK semi-crystalline polyaryletherketone
  • PAEK semi-crystalline polyaryletherketone
  • polymeric materials useful for providing structural prosthetic device parts should possess mechanical properties similar to those of bone. It is generally known that the stiffness of (PAEK) polymers can be increased by adding stiff materials such as reinforcing fillers, in particular glass fibers or carbon fibers however it has the drawback that said reinforced compositions often turn brittle.
  • prosthetic devices comprising at least one part made of a polymeric composition that can overcome the drawbacks, mentioned above, and wherein said polymeric composition features excellent mechanical properties (and in particular good combination of high stiffness and high toughness, strength, elongation properties and impact resistance), having an excellent balance of stiffness and ductility, good processability, high chemical resistance, good biocompatibility and at the same time causing no discoloration or other degradation phenomena, and wherein said polymeric compositions provide thinner, lighter and stiffer parts, and the final parts and prosthetic devices have improved properties such as more uniform crystallinity, improved ductility, impact resistance, higher tensile and flex modulus as well as strength and moreover improved aesthetics, especially an improved, lighter color.
  • a cranial plate 1 in situ within an aperture cut into the skull 2 ; in Fig. 2 an insert 3 in a long bone 4 from which part of the bone had been removed ; and in Fig. 3 a femur head replacement 5 in situ within a femur 6.
  • This last device comprises a core component 7 of a cement composition as described in European Patent Specification No. 21682 and comprising a core component 7 and/or a surface coating 8 of the polymer composition (C) a bearing surface 9 of titanium and a fibrous surface layer 10.
  • a bone plate shown in perspective in Fig. 4 is shown also in enlarged section in Fig. 5 , to illustrate the use of the polymer composition (C) outer coating 11 upon a core region comprising a composite of carbon fibre with the polymer composition (C).
  • Fig. 6 shows the presence of the polymer composition (C) 13 also after refilling of the screw holes and redrilling.
  • composition (C), herein after] comprising
  • the prosthetic device The prosthetic device
  • Prosthetic device is intended to denote an artificial device which is made to replace and act as a missing biological structure.
  • Prosthetic devices may have structural features which make them suitable to act as reinforcement or replacement of a missing or defective animal or human body part, e.g. a bone implant.
  • Prosthetic devices of many shapes, configurations and properties are commonly employed within the living body. They can be used to replace parts lost by injury (traumatic or chirurgical) or missing from birth (congenital) or to supplement defective body parts.
  • part of a prosthetic device is intended to denote a piece or portion which is combined with others to make up the whole prosthetic device.
  • the external coating of a prosthetic device falls thus within this scope.
  • the prosthetic device of the present invention may comprise additional parts. Additional parts are intended to denote parts of the prosthetic devices which do not aim to replace a part of the body as such, but perform a supplementary function. For instance, it may comprise metal inserts, structural reinforcements, radio-opaque inserts, moving motor-driven assemblies, electronic devices, controlling units and the like.
  • the prosthetic device according to the present invention may be an orthopaedic prosthesis for building and/or repairing and/or improving surface properties of skeletal bones and joints such as, but not limited to ligaments, tendons, cartilage, bones, hip joints, knee prosthesis, spinal disc orthoprosthesis.
  • Orthopaedic prostheses comprise manufactured replacements for the ends and articulating surfaces of the bones of the skeleton. Such prostheses are generally implanted to repair or reconstruct all or part of an articulating skeletal joint that is functioning abnormally due to disease, trauma or congenital defect. Other forms of implantable orthopaedic prostheses, beyond providing manufactured replacements for the ends and articulating surfaces of the bones of the skeletal joints, also provide manufactured replacements for portions of the bones distant from the articulating surface. These other forms may be used in cases of abnormally extensive atrophy or resorption of bone in the vicinity of the articulating surface or prior implant, or in cases where an extensive amount of bone is to be intentionally resected to treat oncological or other diseases of the bone.
  • implantable orthopaedic implants designed for such cases often include means for attaching bone and/or soft tissue directly to the implant. Generally such means also provide an initial mechanical attachment, supplemented by later ingrowth and ongrowth of the bone and soft tissue to the prosthesis.
  • the prosthetic device of the present invention may be selected from the group consisting of :
  • At least one polyaryletherketone polymer [(PAEK) polymer] is intended to denote one or more than one (PAEK) polymer.
  • Mixtures of (PAEK) polymer can be advantageously used for the purposes of the invention.
  • (PAEK) polymer are understood, for the purposes of the present invention, both in the plural and the singular, that is to say that the inventive composition may comprise one or more than one (PAEK) polymer.
  • polyaryletherketone PAEK
  • PEEK polyaryletherketone
  • R PAEK recurring units
  • Ar and Ar' equal to or different from each other, being aromatic groups.
  • the recurring units (R PAEK ) are generally selected from the group consisting of formulae (J-A) to (J-O), herein below : wherein :
  • the respective phenylene moieties may independently have 1,2-, 1,4- or 1,3 -linkages to the other moieties different from R' in the recurring unit.
  • said phenylene moieties have 1,3-or 1,4- linkages, more preferably they have 1,4-linkage.
  • j' is at each occurrence zero, that is to say that the phenylene moieties have no other substituents than those enabling linkage in the main chain of the polymer.
  • Preferred recurring units (R PAEK ) are thus selected from those of formulae (J'-A) to (J'-O) herein below :
  • substantially all recurring units of the (PAEK) polymer are recurring units (R PAEK ), as detailed above ; chain defects, or very minor amounts of other units might be present, being understood that these latter do not substantially modify the properties of (R PAEK ).
  • the (PAEK) polymer may be notably a homopolymer, a random, alternate or block copolymer.
  • the (PAEK) polymer may notably contain (i) recurring units (R PAEK ) of at least two different formulae chosen from formulae (J-A) to (J-O), or (ii) recurring units (R PAEK ) of one or more formulae (J-A) to (J-O) and recurring units (R* PAEK ) different from recurring units (R PAEK ).
  • the (PAEK) polymer may be a polyetheretherketone polymer [(PEEK) polymers, herein after].
  • the (PAEK) polymer may be a polyetherketoneketone polymer [(PEKK) polymer, herein after], a polyetherketone polymer [(PEK) polymer, hereinafter], a polyetheretherketoneketone polymer [(PEEKK) polymer, herein after], or a polyetherketoneetherketoneketone polymer [(PEKEKK) polymer, herein after].
  • the (PAEK) polymer may also be a blend composed of at least two different (PAEK) polymers chosen from the group consisting of (PEKK) polymers, (PEEK) polymers, (PEK) polymers and (PEKEKK) polymers, as above detailed.
  • (PEEK) polymer is intended to denote any polymer of which more than 50 % by moles of the recurring units are recurring units (R PAEK ) of formula J'-A.
  • more than 75 % by moles, preferably more than 85 % by moles, preferably more than 95 % by moles, preferably more than 99 % by moles of the recurring units of the (PEEK) polymer are recurring units of formula J'-A. Most preferably all the recurring units of the (PEEK) polymer are recurring units of formula J'-A.
  • (PEKK) polymer is intended to denote any polymer of which more than 50 % by moles of the recurring units are recurring units (R PAEK ) of formula J'-B.
  • more than 75 % by moles, preferably more than 85 % by moles, preferably more than 95 % by moles, preferably more than 99 % by moles of the recurring units of the (PEKK) polymer are recurring units of formula J'-B. Most preferably all the recurring units of the (PEKK) polymer are recurring units of formula J'-B.
  • (PEK) polymer is intended to denote any polymer of which more than 50 % by moles of the recurring units are recurring units (R PAEK ) of formula J'-C.
  • more than 75 % by moles, preferably more than 85 % by moles, preferably more than 95 % by moles, preferably more than 99 % by moles of the recurring units of the (PEK) polymer are recurring units of formula J'-C. Most preferably all the recurring units of the (PEK) polymer are recurring units of formula J'-C.
  • (PEEKK) polymer is intended to denote any polymer of which more than 50 % by moles of the recurring units are recurring units (R PAEK ) of formula J'-M.
  • more than 75 % by moles, preferably more than 85 % by moles, preferably more than 95 % by moles, preferably more than 99 % by moles of the recurring units of the (PEEKK) polymer are recurring units of formula J'-M. Most preferably all the recurring units of the (PEEKK) polymer are recurring units of formula J'-M.
  • (PEKEKK) polymer is intended to denote any polymer of which more than 50 % by moles of the recurring units are recurring units (R PAEK ) of formula J'-L.
  • more than 75 % by moles, preferably more than 85 % by moles, preferably more than 95 % by moles, preferably more than 99 % by moles of the recurring units of the (PEKEKK) polymer are recurring units of formula J'-L. Most preferably all the recurring units of the (PEKEKK) polymer are recurring units of formula J'-L.
  • the (PAEK) polymer was a (PEEK) homopolymer, i.e. a polymer of which substantially all the recurring units of the (PEEK) polymer are recurring units of formula J'-A, wherein chain defects, or very minor amounts of other units might be present, being understood that these latter do not substantially modify the properties of the (PEEK) homopolymer.
  • a (PEEK) homopolymer i.e. a polymer of which substantially all the recurring units of the (PEEK) polymer are recurring units of formula J'-A, wherein chain defects, or very minor amounts of other units might be present, being understood that these latter do not substantially modify the properties of the (PEEK) homopolymer.
  • Non limitative examples of commercially available polyaryletherketone (PAEK) resins suitable for the invention include the KETASPIRE ® polyetheretherketone commercially available from Solvay Specialty Polymers USA, LLC.
  • IV intrinsic viscosity
  • the measurement is generally performed using a No 50 Cannon-Fleske viscometer ; IV is measured at 25°C in a time less than 4 hours after dissolution.
  • the (PAEK) polymer has a melt viscosity of advantageously at least 0.05 kPa.s, preferably at least 0.08 kPa.s, more preferably at least 0.1 kPa.s, still more preferably at least 0.12 kPa.s at 400°C and a shear rate of 1000 s -1 , as measured using a capillary rheometer in accordance with ASTM D3835.
  • a Kayeness Galaxy V Rheometer (Model 8052 DM) can be used.
  • the PAEK polymer has a melt viscosity of advantageously at most 1.00 kPa.s, preferably at most 0.80 kPa.s, more preferably at most 0.70 kPa.s, even more preferably at most 0.60 kPa.s, most preferably at most 0.50 kPa.s at 400°C and a shear rate of 1000 s -1 , as measured using a capillary rheometer in accordance with ASTM D3835.
  • the (PAEK) polymer can be prepared by any method known in the art for the manufacture of poly(aryl ether ketone)s.
  • NI nitride
  • nitride nitride
  • NI nitride
  • Mixtures of nitrides can be advantageously used for the purposes of the invention.
  • an "element” is intended to denote an element from the Periodic Table of the Elements.
  • Non limitative examples of nitrides (NI) of an element having an electronegativity ( ⁇ ) of from 1.3 to 2.5 are listed « Handbook of Chemistry and Physics » CRC Press, 64 th edition, pages B-65 to B-158. The code into brackets is the one attributed by the CRC Handbook to the concerned nitride, while ⁇ denotes the electronegativity of the element from which the nitride is derived.
  • the nitride (NI) is a nitride of an element having an electronegativity of preferably at least 1.6, and more preferably at least 1.8.
  • the nitride (NI) is the nitride of an element having an electronegativity of preferably at most 2.2.
  • nitride is chosen preferably from nitrides of an element chosen from Groups IIIa, IVa, IVb, Va, Vb, VIa, VIb, VIIb and VIII of the Periodic Table of the Elements, and more preferably from nitrides of an element of Group IIIa of the Periodic Table of the Elements.
  • nitride boron nitride
  • the Applicant has surprisingly found that the presence of the nitride (NI), as described above, is effective in enhancing the stiffness of the composition (C) while maintaining the ductility of the unmodified PAEK polymer used thus far, thereby offering said composition (C) of the invention superior properties which allows them to be very useful as being comprised in parts of the prosthetic devices.
  • NI nitride
  • the average particle size of the nitride (NI) may play a role in improving mechanical properties such as in particular the stiffness and the tensile elongation at break of the composition (C) and in improving the aesthetics aspects, especially in improved the color of the composition (C).
  • the average particle size of the nitride (NI) is advantageously equal to or below 30 ⁇ m, preferably equal to or below 20 ⁇ m, more preferably equal to or below 18 ⁇ m, more preferably equal to or below 10 ⁇ m.
  • the average particle size of the nitride (NI) is preferably equal to or at least 0.05 ⁇ m, equal to or at least 0.1 ⁇ m, more preferably equal to or at least 0.2 ⁇ m, equal to or at least 1 ⁇ m.
  • the average particle size of the nitride (NI) is preferably from 1 ⁇ m to 20 ⁇ m, more preferably from 2 ⁇ m to 18 ⁇ m, more preferably from 2 ⁇ m to 10 ⁇ m.
  • NI nitride
  • the average particle size of the nitride (NI) is measured via light scattering techniques (dynamic or laser) using the respective equipment coming for example from the company Malvern (Mastersizer Micro or 3000) or using screen analysis according to DIN 53196.
  • composition (C) of the present invention advantageously comprises the nitride (NI) in an amount of at least 1.0 % wt, preferably at least 1.10 % wt, more preferably at least 2.0 % wt, most preferably at least 5.0 % wt based on the total weight of the composition (C).
  • nitride (NI) present in the composition (C) of the present invention.
  • the composition (C) of the present invention advantageously comprises the nitride (NI) in an amount of at most 50.0 % wt, preferably at most 40.0 % wt, more preferably at most 30.0 % wt, even more preferably at most 20.0 % wt, still more preferably at most 15.0 % wt, and most preferably at most 10.0 % wt, based on the total weight of the composition (C).
  • NI nitride
  • composition (C) of the present invention advantageously comprises the nitride (NI) in an amount ranging from 2 to 50 % wt, more preferably from 5 to 20 % wt, even more preferably from 5 to 10 % wt, based on the total weight of the composition (C).
  • the total weight of the the (PAEK) polymer, based on the total weight of the composition (C), is advantageously above 50 %, preferably above 60 % ; more preferably above 70 % ; more preferably above 80 %, more preferably above 85 %.
  • composition (C) consists of the (PAEK) polymer and the nitride (NI).
  • a preferred composition (C) of the invention thus includes a (PAEK) polymer, as above detailed, and more preferably a (PAEK) polymer comprising recurring units (R PAEK ) of formula (J'-A), as above detailed and boron nitride in an amount of 5 to 15 % wt, based on the total weight of the composition (C).
  • a (PAEK) polymer as above detailed, and more preferably a (PAEK) polymer comprising recurring units (R PAEK ) of formula (J'-A), as above detailed and boron nitride in an amount of 5 to 15 % wt, based on the total weight of the composition (C).
  • composition (C) of the present invention may further comprise at least one other thermoplastic polymer (polymer T).
  • Non limitative examples of polymers (T) suitable for use in composition (C) of the present invention include for example polyarylethersulfones, polyphenylenes, polyimides, more notably polyetherimides, and polyphenylene sulfides.
  • the weight of said other polymers is advantageously below 40 % wt, preferably below 30 % wt, and more preferably below 25 % wt based on the total weight of the composition (C).
  • composition (C) can further comprise one or more ingredients other than the (PAEK) polymer [ingredient (I), herein after].
  • Non limitative examples of ingredient (I) suitable for use in composition (C) of the present invention are polymeric compositions, additives such as UV absorbers ; stabilizers such as light stabilizers and heat stabilizers ; antioxidants ; lubricants ; processing aids ; plasticizers ; flow modifiers ; flame retardants ; pigments such as notably titanium dioxide (TiO 2 ) ; dyes ; colorants ; anti-static agents ; extenders ; metal deactivators ; conductivity additive such as carbon black and carbon nanofibrils and combinations comprising one or more of the foregoing additives.
  • additives such as UV absorbers ; stabilizers such as light stabilizers and heat stabilizers ; antioxidants ; lubricants ; processing aids ; plasticizers ; flow modifiers ; flame retardants ; pigments such as notably titanium dioxide (TiO 2 ) ; dyes ; colorants ; anti-static agents ; extenders ; metal deactivators ; conductivity additive
  • the weight of said ingredient (I) is advantageously below 10 % wt and preferably below 5 % wt, based on the total weight of the composition (C).
  • the composition (C) comprises more than 80 wt % of the (PAEK) polymer with the proviso that the (PAEK) polymer is the only polymeric components in the composition (C) and one or more optional ingredient such as notably UV absorbers ; stabilizers such as light stabilizers and heat stabilizers ; antioxidants ; lubricants ; processing aids ; plasticizers ; flow modifiers ; flame retardants ; pigments such as notably titanium dioxide (TiO 2 ) ; dyes ; colorants ; anti-static agents ; extenders ; metal deactivators ; conductivity additive such as carbon black and carbon nanofibrils might be present therein, without these components dramatically affecting relevant mechanical and toughness properties of the composition (C).
  • one or more optional ingredient such as notably UV absorbers ; stabilizers such as light stabilizers and heat stabilizers ; antioxidants ; lubricants ; processing aids ; plasticizers ; flow modifiers ; flame retardants ; pigments
  • polymeric components' is to be understood according to its usual meaning, i.e. encompassing compounds characterized by repeated linked units, having typically a molecular weight of 2 000 or more.
  • the polymer composition (C) may further comprise at least one reinforcing filler.
  • Reinforcing fillers are well known by the skilled in the art. They are preferably selected from fibrous and particulate fillers different from the pigment as defined above. More preferably, the reinforcing filler is selected from mineral fillers (such as talc, mica, kaolin, calcium carbonate, calcium silicate, magnesium carbonate), glass fiber, carbon fibers, synthetic polymeric fiber, aramid fiber, aluminum fiber, titanium fiber, magnesium fiber, boron carbide fibers, rock wool fiber, steel fiber, wollastonite etc. Still more preferably, it is selected from mica, kaolin, calcium silicate, magnesium carbonate, glass fiber, carbon fibers and wollastonite etc.
  • the filler is chosen from fibrous fillers.
  • a particular class of fibrous fillers consists of whiskers, i.e. single crystal fibers made from various raw materials, such as Al 2 O 3 , SiC, BC, Fe and Ni.
  • the reinforcing filler is chosen from wollastonite and glass fiber.
  • glass fibers are preferred ; they include chopped strand A-, E-, C-, D-, S-, T- and R-glass fibers, as described in chapter 5.2.3, p. 43-48 of Additives for Plastics Handbook, 2 nd edition, John Murphy.
  • Glass fibers optionally comprised in polymer composition (C) may have a circular cross-section or a non-circular cross-section (such as an oval or rectangular cross-section).
  • the glass fibers used have a circular cross-section, they preferably have an average glass fiber diameter of 3 to 30 ⁇ m and particularly preferred of 5 to 12 ⁇ m.
  • Different sorts of glass fibers with a circular cross-section are available on the market depending on the type of the glass they are made of.
  • the reinforcing filler is a carbon fiber.
  • carbon fiber is intended to include graphitized, partially graphitized and ungraphitized carbon reinforcing fibers or a mixture thereof.
  • Carbon fibers useful for the present invention can advantageously be obtained by heat treatment and pyrolysis of different polymer precursors such as, for example, rayon, polyacrylonitrile (PAN), aromatic polyamide or phenolic resin ; carbon fibers useful for the present invention may also be obtained from pitchy materials.
  • the term “graphite fiber” intends to denote carbon fibers obtained by high temperature pyrolysis (over 2000°C) of carbon fibers, wherein the carbon atoms place in a way similar to the graphite structure.
  • Carbon fibers useful for the present invention are preferably chosen from the group composed of PAN-based carbon fibers, pitch based carbon fibers, graphite fibers, and mixtures thereof.
  • the weight of said reinforcing filler is advantageously preferably below 60 % wt, more preferably below 50 % wt, even more preferably below 45 % wt, most preferably below 35 % wt, based on the total weight of the composition (C).
  • the reinforcing filler is present in an amount ranging from 10 to 60 % wt, preferably from 20 to 50 % wt, preferably from 25 to 45 % wt, most preferably from 25 to 35 % wt, based on the total weight of the polymer composition (C).
  • composition (C) can be prepared by a variety of methods involving intimate admixing of the polymer materials with any optional ingredient, as detailed above, desired in the formulation, for example by melt mixing or a combination of dry blending and melt mixing.
  • dry blending of the (PAEK) polymer and the nitride (NI), and optionally the polymers (T), optionally the reinforcing filler and optionally ingredient (I), as above details is carried out by using high intensity mixers, such as notably Henschel-type mixers and ribbon mixers.
  • So obtained powder mixture can comprise the (PAEK) polymer and the nitride (NI), and optionally the polymers (T), optionally the reinforcing filler and optionally ingredient (I), in the weight ratios as above detailed, suitable for obtaining effective formation of the above described parts of a prosthetic device, or can be a concentrated mixture to be used as masterbatch and diluted in further amounts of the (PAEK) polymer and the nitride (NI), and optionally the polymers (T), optionally the reinforcing filler and optionally ingredient (I) in subsequent processing steps.
  • melt compounding can be effected on the powder mixture as above detailed, or preferably directly on the (PAEK) polymer and the nitride (NI), and optionally the polymers (T), optionally the reinforcing filler and optionally ingredient (I).
  • melt compounding devices such as co-rotating and counterrotating extruders, single screw extruders, co-kneaders, disc-pack processors and various other types of extrusion equipment can be used.
  • extruders more preferably twin screw extruders can be used.
  • the design of the compounding screw e.g. flight pitch and width, clearance, length as well as operating conditions will be advantageously chosen so that sufficient heat and mechanical energy is provided to advantageously fully melt the powder mixture or the ingredients as above detailed and advantageously obtain a homogeneous distribution of the different ingredients.
  • optimum mixing is achieved between the bulk polymer and filler contents.
  • strand extrudates which are not ductile of the composition (C) of the invention.
  • Such strand extrudates can be chopped by means e.g. of a rotating cutting knife after some cooling time on a conveyer with water spray.
  • composition (C) which may be present in the form of pellets or beads can then be further used for the manufacture of the above described part of a prosthetic device.
  • Another objective of the present invention is to provide a method for the manufacture of the above described part of a prosthetic device device. Such method is not specifically limited.
  • the polymer composition (C) may be generally processed by injection molding, extrusion or other shaping technologies.
  • the method for the manufacture of the above described part of a mobile electronic device includes the step of injection molding and solidification of the polymer composition (C).
  • the method for the manufacture of the above described part of a prosthetic device includes the machining of a standard shaped structural part in a part having any type of size and shape.
  • a standard shaped structural part include notably a plate, a rod, a slab and the like.
  • Said standard shaped structural parts can be obtained by extrusion or injection molding of the polymer composition (C).
  • Another object of the invention is a part of a prosthetic device comprising the polymer composition as above described.
  • composition (C) of the present invention is effective in providing prosthetic device parts having higher stiffness than devices of the prior art while at the same time not sacrificing the ductility, elongation, toughness and impact resistance properties of the unmodified PAEK resin that has been used thus far.
  • Impact resistance is particularly important in prosthetic applications because in many cases the surgeon has to hammer the part into position.
  • said prosthetic device parts comprising the composition (C) of the present invention have improved aesthetics, in particular improved lighter color and said prosthetic device parts have a higher acceptance for many applications where color is a concern, as notably in dental applications, and other cosmetic applications.
  • KetaSpire ® PEEK KT-820P is polyetheretherketone polymer commercially available from Solvay Specialty Polymers USA, LLC.
  • a dry blend of PEEK resins with the desired amounts of Boronid ® S1-SF or Boronid ® S15 were prepared by first tumble blending for about 20 minutes, followed by melt compounding using an 25 mm Berstorff co-rotating partially intermeshing twin screw extruder having an L/D ratio of 40:1.
  • the extruder had 8 barrel sections with barrel sections 2 through 8 being heated sections. Vacuum venting was applied at barrel section 7 with 18-20 in of vacuum during compounding to strip off moisture and any possible residual volatiles from the compound.
  • the compounding temperature profile was such that barrel sections 2-5 were set at 330°C while barrel sections 5-8 and the die adapter were set at 340°C.
  • the screw speed used 180 throughout and the throughput rate was 15-17 lb/hr, whereas the melt temperature, measured manually for each formulation molten extrudate, at the exit of the extruder die ranged from 398 to 402°C.
  • the extrudate for each formulation was cooled in a water trough and then pelletized using a pelletizer.
  • the thus obtained pellets of the four blends were next dried for 4 hours in a desiccated air oven at 150°C and subjected to mechanical testing. Said pellets were injection-molded to produce ASTM test specimens using a Toshiba 150 ton injection molding machine following standard conditions and guidelines for KetaSpire KT-820 PEEK resin provided by the supplier Solvay Specialty Polymers.
  • HDT was measured at an applied stress of 264 psi and using 0.125 in-thick flexural specimens annealed at 200°C for 2 hours to assure uniform crystallinity and removal of residual molded-in stresses in the parts which can otherwise compromise the accuracy of the measurement.
  • the color of 4 in x 4 in x 0.125 injection molded plaques injection molded color plaques was measured according to ASTM E308-06 using illuminant D65 (white light simulating daylight) at 10° angle (1964 CIE).
  • L*, a* and b* color coordinates were measured using a Gretag Macbeth Color Eye Ci5 Spectrophotometer, with tribeam diffuse/8 "6" sphere optical geometry, a bandpass of 10 nm, a spectral range of 360 nm to 750 nm per CIE Lab standards using illuminant D65 and a 10 degree observer.
  • the L, a and b color coordinates measured by this test correspond to the lightness scale (L), green-red hue scale (a) and the blue-yellow hue scale (b).
  • Carbon fiber-reinforced PEEK formulations described in Table 2 were prepared by melt compounding using a twin screw co-rotating intermeshing extruder equipped with 8 barrel sections and an overall L/D ratio of 40.
  • the PEEK powder was tumble blended with either the boron nitride or fed as is (in the case of the Control) in the feed hopper of the extruder.
  • the carbon fiber was fed gravimetrically at the required proportion and was metered at a feed port on barrel section 5 of the extruder.
  • a vacuum vent port at barrel section 7 was used to pull high vacuum on the melt to remove any residual moisture or organic volatiles that may evolve from the sizing of the carbon fiber.
  • the compounded formulations were stranded using a one-hole 3 mm diameter and were cooled on a conveyor belt with a water spray before being fed to a pelletizer to chop the extrudate into pellets. Details of the compounding conditions are shown in Table 3.
  • Comparative Example 10 (C10) 11 Comparative Example 12 (C12) Barrel Zone Temperature (°C) Barrel Section 1 No Heat No Heat No Heat Barrel Section 2 (Set Point/Actual) 330/329 330/330 330/329 Barrel Section 3 (Set Point/Actual) 330/330 330/330 330/330 Barrel Section 4 (Set Point/Actual) 330/331 330/330 330/331 Barrel Section 5 (Set Point/Actual) 330/ 334 330/ 332 330/ 332 Barrel Section 6 (Set Point/Actual) 340/ 343 340/342 340/341 Barrel Section 7 (Set Point/Actual) 340/342 340/342 340/340 Barrel Section 8 (Set Point/Actual) 340/340 340/342 340/341 Adapter (Set Point/Actual) 340/340 340/341 340/ 341 Die (Set Point/Actual) 340/340 340/341 340/341 Actual Mel

Description

  • This application claims priority to U.S. provisional application No. 61/740292 filed on 20 December 2012 and to European application No. 13154978.4 filed on 12 February 2013 , the whole content of each of these applications being incorporated herein by reference for all purposes.
  • Field of invention
  • The present invention is related to a prosthetic device comprising at least one structural part made of a poly(aryletherketone) polymer composition wherein said poly(aryletherketone) polymer composition is characterized by having improved mechanical properties, in particular having an excellent balance of stiffness and ductility, and thus are providing structural parts to be thinner and maintaining high stiffness.
  • Background of the invention
  • Due both to demographic change and to developments in medical science, the number of surgical procedures involving prosthesis implantation is rising rapidly. The more obvious examples of prosthetic devices are hip or knee replacements and false teeth. Other less well-known examples are stents, heart valves, bone screws and plates and spinal fixators.
  • Prosthesis must be tolerated by the patient and not altered in time. Materials that may be suitable for each type of prosthesis are subjected to precise specifications. Indeed, if the prosthesis is a dental implant or a hip replacement the specifications will be very different.
  • The most important requirements are mechanical properties similar to those of bone to allow the transfer constraints between bone and prosthesis, chemical resistance to corrosion, chemical inertia in relation to the environment and biocompatibility. These properties must be controlled to maintain the integrity of used materials. The human body is an aggressive and corrosive environment mainly because of concentrations of chloride ions (113 mEq/l in blood plasma and 117 mEq/l in the interstitial fluid, which is sufficient to corrode metallic materials) and dissolved oxygen.
  • For dental implants, conditions are even tougher since the saliva contains more sulfur products that make it still more corrosive. The term "biocompatibility" is defined by the Dorland's Medical Dictionnary as the quality of not having toxic or injurious effects on biological systems. This encompasses both the material and host responses to an implant. The host response to an implant can be highly complex and is often linked to the material response. It is also dependent on the anatomical position of the implant. For a material to be biocompatible, it should not elicit any adverse host reactions to its presence. Inflammation and encapsulation phenomena may occur when the prosthesis suffer from low biocompatibility.
  • For some of the implants, as notably for dental implants, some challenging aesthetic requirements such as notably having very low discoloration effects of said implants also might be important.
  • Typically, prosthetic devices are made of inorganic (metal, alloys, ceramic and glass) and/or polymeric materials.
  • It should be noted that metals have the drawback that they are too stiff, and preventing the bone from bearing as much weight and causing the surrounding bone to disappear.
  • The use of polymeric materials for the manufacturing of prosthetic devices are for example described in U.S. 2007111165 whereby a prosthetic dental device is made of a thermoplastic polymer including a poly(aryl ketone), such as poly(ether ether ketone) (PEEK), polymethylmethacrylate (PMMA), poly(aryl ether ketone) (PAEK), poly(ether ketone) (PEK), poly(ether ketone ether ketone ketone) (PEKEKK), poly(ether ketone ketone) (PEKK), and/or polyetherimide (PEI), polysulfone (PSU), and polyphenylsulfone (PPSU).
  • The use of semi-crystalline polyaryletherketone (PAEK) polymers are for example also described in U.S. 4,662,887 . Semi-crystalline (PAEK) polymers are suitable polymeric materials for use in the manufacturing of prosthetic devices, because said semi-crystalline polyaryletherketone (PAEK) polymers are known for their light weight, their exceptional balance of technical properties, namely high melting point, good thermal stability, high stiffness and strength, good toughness and really excellent chemical resistance (including environmental stress cracking resistance) and outstanding fatigue resistance, in addition to inertness to the body's environment.
  • As mentioned above, polymeric materials useful for providing structural prosthetic device parts should possess mechanical properties similar to those of bone. It is generally known that the stiffness of (PAEK) polymers can be increased by adding stiff materials such as reinforcing fillers, in particular glass fibers or carbon fibers however it has the drawback that said reinforced compositions often turn brittle.
  • Thus, there remains a continuous need for prosthetic devices comprising at least one part made of a polymeric composition that can overcome the drawbacks, mentioned above, and wherein said polymeric composition features excellent mechanical properties (and in particular good combination of high stiffness and high toughness, strength, elongation properties and impact resistance), having an excellent balance of stiffness and ductility, good processability, high chemical resistance, good biocompatibility and at the same time causing no discoloration or other degradation phenomena, and wherein said polymeric compositions provide thinner, lighter and stiffer parts, and the final parts and prosthetic devices have improved properties such as more uniform crystallinity, improved ductility, impact resistance, higher tensile and flex modulus as well as strength and moreover improved aesthetics, especially an improved, lighter color.
  • Brief description of the figures
  • Illustrated in sectional view in the drawings are, in Fig. 1, a cranial plate 1 in situ within an aperture cut into the skull 2 ; in Fig. 2 an insert 3 in a long bone 4 from which part of the bone had been removed ; and in Fig. 3 a femur head replacement 5 in situ within a femur 6.
  • This last device comprises a core component 7 of a cement composition as described in European Patent Specification No. 21682 and comprising a core component 7 and/or a surface coating 8 of the polymer composition (C) a bearing surface 9 of titanium and a fibrous surface layer 10.
  • A bone plate shown in perspective in Fig. 4 is shown also in enlarged section in Fig. 5, to illustrate the use of the polymer composition (C) outer coating 11 upon a core region comprising a composite of carbon fibre with the polymer composition (C). Fig. 6 shows the presence of the polymer composition (C) 13 also after refilling of the screw holes and redrilling.
  • Summary of invention
  • The present invention addresses the above detailed needs and relates to a prosthetic device comprising at least one part made of a polymer composition [composition (C), herein after] comprising
    1. (i) at least one polyaryletherketone polymer [(PAEK) polymer],
    2. (ii) at least one nitride (NI) of an element having an electronegativity (ε) of from 1.3 to 2.5, as defined in « Handbook of Chemistry and Physics », CRC Press, 64th edition, pages B-65 to B-158.
    The prosthetic device
  • To the purposes of the invention, the term "prosthetic device" is intended to denote an artificial device which is made to replace and act as a missing biological structure. Prosthetic devices may have structural features which make them suitable to act as reinforcement or replacement of a missing or defective animal or human body part, e.g. a bone implant. Prosthetic devices of many shapes, configurations and properties are commonly employed within the living body. They can be used to replace parts lost by injury (traumatic or chirurgical) or missing from birth (congenital) or to supplement defective body parts.
  • For the sake of clarity, the term "part of a prosthetic device" is intended to denote a piece or portion which is combined with others to make up the whole prosthetic device. The external coating of a prosthetic device falls thus within this scope.
  • The prosthetic device of the present invention may comprise additional parts. Additional parts are intended to denote parts of the prosthetic devices which do not aim to replace a part of the body as such, but perform a supplementary function. For instance, it may comprise metal inserts, structural reinforcements, radio-opaque inserts, moving motor-driven assemblies, electronic devices, controlling units and the like.
  • The prosthetic device according to the present invention may be an orthopaedic prosthesis for building and/or repairing and/or improving surface properties of skeletal bones and joints such as, but not limited to ligaments, tendons, cartilage, bones, hip joints, knee prosthesis, spinal disc orthoprosthesis.
  • Orthopaedic prostheses comprise manufactured replacements for the ends and articulating surfaces of the bones of the skeleton. Such prostheses are generally implanted to repair or reconstruct all or part of an articulating skeletal joint that is functioning abnormally due to disease, trauma or congenital defect. Other forms of implantable orthopaedic prostheses, beyond providing manufactured replacements for the ends and articulating surfaces of the bones of the skeletal joints, also provide manufactured replacements for portions of the bones distant from the articulating surface. These other forms may be used in cases of abnormally extensive atrophy or resorption of bone in the vicinity of the articulating surface or prior implant, or in cases where an extensive amount of bone is to be intentionally resected to treat oncological or other diseases of the bone. Because the natural bony areas to which ligaments, tendons and other soft tissues attach are often lost to such extensive resections of the bone, implantable orthopaedic implants designed for such cases often include means for attaching bone and/or soft tissue directly to the implant. Generally such means also provide an initial mechanical attachment, supplemented by later ingrowth and ongrowth of the bone and soft tissue to the prosthesis.
  • For example, the prosthetic device of the present invention may be selected from the group consisting of :
    • orthopaedic prosthesis such as ligaments, tendons, cartilage, bones, hip joints, knee prosthesis, spinal disc orthoprosthesis ;
    • dental structures such as dentures, partial dentures ;
    • prosthetic structures for other body parts, such as prosthetic devices that serve as artificial body parts including limbs, eyes, implants, included cosmetic implants, hearing aids, and the like, such as spectacle frames ;
    • fixed prosthetic anatomical devices such as caps, crowns and other non-dental anatomical replacement structures.
    The polyaryletherketone polymer
  • Within the context of the present invention the mention "at least one polyaryletherketone polymer [(PAEK) polymer]" is intended to denote one or more than one (PAEK) polymer. Mixtures of (PAEK) polymer can be advantageously used for the purposes of the invention.
  • In the rest of the text, the expressions "(PAEK) polymer" are understood, for the purposes of the present invention, both in the plural and the singular, that is to say that the inventive composition may comprise one or more than one (PAEK) polymer.
  • For the purpose of the invention, the term "polyaryletherketone (PAEK)" is intended to denote any polymer, comprising recurring units, more than 50 % moles of said recurring units are recurring units (RPAEK) comprising a Ar-C(O)-Ar' group, with Ar and Ar', equal to or different from each other, being aromatic groups. The recurring units (RPAEK) are generally selected from the group consisting of formulae (J-A) to (J-O), herein below :
    Figure imgb0001
    Figure imgb0002
    Figure imgb0003
    Figure imgb0004
    Figure imgb0005
    Figure imgb0006
    Figure imgb0007
    Figure imgb0008
    Figure imgb0009
    Figure imgb0010
    Figure imgb0011
    Figure imgb0012
    Figure imgb0013
    Figure imgb0014
    Figure imgb0015
    wherein :
    • each of R', equal to or different from each other, is selected from the group consisting of halogen, alkyl, alkenyl, alkynyl, aryl, ether, thioether, carboxylic acid, ester, amide, imide, alkali or alkaline earth metal sulfonate, alkyl sulfonate, alkali or alkaline earth metal phosphonate, alkyl phosphonate, amine and quaternary ammonium ;
    • j' is zero or is an integer from 0 to 4.
  • In recurring unit (RPAEK), the respective phenylene moieties may independently have 1,2-, 1,4- or 1,3 -linkages to the other moieties different from R' in the recurring unit. Preferably, said phenylene moieties have 1,3-or 1,4- linkages, more preferably they have 1,4-linkage.
  • Still, in recurring units (RPAEK), j' is at each occurrence zero, that is to say that the phenylene moieties have no other substituents than those enabling linkage in the main chain of the polymer.
  • Preferred recurring units (RPAEK) are thus selected from those of formulae (J'-A) to (J'-O) herein below :
    Figure imgb0016
    Figure imgb0017
    Figure imgb0018
    Figure imgb0019
    Figure imgb0020
    Figure imgb0021
    Figure imgb0022
    Figure imgb0023
    Figure imgb0024
    Figure imgb0025
    Figure imgb0026
    Figure imgb0027
    Figure imgb0028
    Figure imgb0029
    Figure imgb0030
  • In the (PAEK) polymer, as detailed above, preferably more than 60 %, more preferably more than 80 %, still more preferably more than 90 % moles of the recurring units are recurring units (RPAEK), as above detailed.
  • Still, it is generally preferred that substantially all recurring units of the (PAEK) polymer are recurring units (RPAEK), as detailed above ; chain defects, or very minor amounts of other units might be present, being understood that these latter do not substantially modify the properties of (RPAEK).
  • The (PAEK) polymer may be notably a homopolymer, a random, alternate or block copolymer. When the (PAEK) polymer is a copolymer, it may notably contain (i) recurring units (RPAEK) of at least two different formulae chosen from formulae (J-A) to (J-O), or (ii) recurring units (RPAEK) of one or more formulae (J-A) to (J-O) and recurring units (R*PAEK) different from recurring units (RPAEK).
  • As will be detailed later on, the (PAEK) polymer may be a polyetheretherketone polymer [(PEEK) polymers, herein after]. Alternatively, the (PAEK) polymer may be a polyetherketoneketone polymer [(PEKK) polymer, herein after], a polyetherketone polymer [(PEK) polymer, hereinafter], a polyetheretherketoneketone polymer [(PEEKK) polymer, herein after], or a polyetherketoneetherketoneketone polymer [(PEKEKK) polymer, herein after].
  • The (PAEK) polymer may also be a blend composed of at least two different (PAEK) polymers chosen from the group consisting of (PEKK) polymers, (PEEK) polymers, (PEK) polymers and (PEKEKK) polymers, as above detailed.
  • For the purpose of the present invention, the term "(PEEK) polymer" is intended to denote any polymer of which more than 50 % by moles of the recurring units are recurring units (RPAEK) of formula J'-A.
  • Preferably more than 75 % by moles, preferably more than 85 % by moles, preferably more than 95 % by moles, preferably more than 99 % by moles of the recurring units of the (PEEK) polymer are recurring units of formula J'-A. Most preferably all the recurring units of the (PEEK) polymer are recurring units of formula J'-A.
  • For the purpose of the present invention, the term "(PEKK) polymer" is intended to denote any polymer of which more than 50 % by moles of the recurring units are recurring units (RPAEK) of formula J'-B.
  • Preferably more than 75 % by moles, preferably more than 85 % by moles, preferably more than 95 % by moles, preferably more than 99 % by moles of the recurring units of the (PEKK) polymer are recurring units of formula J'-B. Most preferably all the recurring units of the (PEKK) polymer are recurring units of formula J'-B.
  • For the purpose of the present invention, the term "(PEK) polymer" is intended to denote any polymer of which more than 50 % by moles of the recurring units are recurring units (RPAEK) of formula J'-C.
  • Preferably more than 75 % by moles, preferably more than 85 % by moles, preferably more than 95 % by moles, preferably more than 99 % by moles of the recurring units of the (PEK) polymer are recurring units of formula J'-C. Most preferably all the recurring units of the (PEK) polymer are recurring units of formula J'-C.
  • For the purpose of the present invention, the term "(PEEKK) polymer" is intended to denote any polymer of which more than 50 % by moles of the recurring units are recurring units (RPAEK) of formula J'-M.
  • Preferably more than 75 % by moles, preferably more than 85 % by moles, preferably more than 95 % by moles, preferably more than 99 % by moles of the recurring units of the (PEEKK) polymer are recurring units of formula J'-M. Most preferably all the recurring units of the (PEEKK) polymer are recurring units of formula J'-M.
  • For the purpose of the present invention, the term "(PEKEKK) polymer" is intended to denote any polymer of which more than 50 % by moles of the recurring units are recurring units (RPAEK) of formula J'-L.
  • Preferably more than 75 % by moles, preferably more than 85 % by moles, preferably more than 95 % by moles, preferably more than 99 % by moles of the recurring units of the (PEKEKK) polymer are recurring units of formula J'-L. Most preferably all the recurring units of the (PEKEKK) polymer are recurring units of formula J'-L.
  • Excellent results were obtained when the (PAEK) polymer was a (PEEK) homopolymer, i.e. a polymer of which substantially all the recurring units of the (PEEK) polymer are recurring units of formula J'-A, wherein chain defects, or very minor amounts of other units might be present, being understood that these latter do not substantially modify the properties of the (PEEK) homopolymer.
  • Non limitative examples of commercially available polyaryletherketone (PAEK) resins suitable for the invention include the KETASPIRE® polyetheretherketone commercially available from Solvay Specialty Polymers USA, LLC.
  • The (PAEK) polymer can have a intrinsic viscosity (IV) of at least 0.50 dl/g, preferably at least 0.60 dl/g, more preferably at least 0.70 dl/g, as measured in 95-98 % sulfuric acid (d= 1.84 g/ml) at a (PAEK) polymer concentration of 0.1 g/100 ml.
  • The IV of the (PAEK) polymer can notably be equal to or less than 1.40 dl/g, preferably equal to or less than 1.30 dl/g, more preferably equal to or less than 1.20 dl/g, most preferably equal to or less than 1.15 dl/g, as measured in 95-98 % sulfuric acid (d= 1.84 g/ml) at a (PAEK) polymer concentration of 0.1 g/100 ml.
  • Good results have been obtained with (PAEK) polymers having an IV from 0.70 dl/g to 1.15 dl/g, as measured in 95-98 % sulfuric acid (d= 1.84 g/ml) at a (PAEK) polymer concentration of 0.1 g/100 ml.
  • The measurement is generally performed using a No 50 Cannon-Fleske viscometer ; IV is measured at 25°C in a time less than 4 hours after dissolution.
  • The (PAEK) polymer has a melt viscosity of advantageously at least 0.05 kPa.s, preferably at least 0.08 kPa.s, more preferably at least 0.1 kPa.s, still more preferably at least 0.12 kPa.s at 400°C and a shear rate of 1000 s-1, as measured using a capillary rheometer in accordance with ASTM D3835.
  • As capillary rheometer, a Kayeness Galaxy V Rheometer (Model 8052 DM) can be used.
  • The PAEK polymer has a melt viscosity of advantageously at most 1.00 kPa.s, preferably at most 0.80 kPa.s, more preferably at most 0.70 kPa.s, even more preferably at most 0.60 kPa.s, most preferably at most 0.50 kPa.s at 400°C and a shear rate of 1000 s-1, as measured using a capillary rheometer in accordance with ASTM D3835.
  • The (PAEK) polymer can be prepared by any method known in the art for the manufacture of poly(aryl ether ketone)s.
  • The nitride (NI)
  • Within the context of the present invention the mention "at least one nitride (NI)" is intended to denote one or more than one nitride (NI). Mixtures of nitrides (NI) can be advantageously used for the purposes of the invention.
  • For the purpose of the present invention, an "element" is intended to denote an element from the Periodic Table of the Elements.
  • The value of the electronegativity of an element that are to be taken into consideration for the purpose of the present invention are those reported in the Periodic Table of the Elements edited by J. Breysem, c/o VEL s.a., "Produits, appareillage et fournitures pour le laboratoire", printed in Belgium in February 1987.
  • Non limitative examples of nitrides (NI) of an element having an electronegativity (ε) of from 1.3 to 2.5 are listed « Handbook of Chemistry and Physics », CRC Press, 64th edition, pages B-65 to B-158. The code into brackets is the one attributed by the CRC Handbook to the concerned nitride, while ε denotes the electronegativity of the element from which the nitride is derived. Then, nitrides (NI) of an element having an electronegativity (ε) of from 1.3 to 2.5 suitable to the purpose of the present invention are notably aluminum nitride (AlN, a45, ε=1.5), antimony nitride (SbN, a271, ε=1.9), beryllium nitride (Be3N2, b123, ε=1.5), boron nitride (BN, b203, ε=2.0), chromium nitride (CrN, c406, ε=1.6), copper nitride (Cu3N, c615, ε=1.9), gallium nitride (GaN, g41, ε=1.6), trigermanium dinitride (Ge3N2, g82, ε=1.8), trigermanium tetranitride (Ge3N4, g83, ε=1.8), hafnium nitride (HfN, h7, ε=1.3), iron nitrides like Fe4N (i151, ε=1.8) and Fe2N or Fe4N2 (i152, ε=1.8), mercury nitride (Hg3N2, m221, ε=1.9), niobium nitride (n109, ε=1.6), silicium nitride (Si3N4, s109, ε=1.8), tantalum nitride (TaN, t7, ε=1.5), titanium nitride (Ti3N4, t249, ε=1.5), wolfram dinitride (WN2, t278, ε=1.7), vanadium nitride (VN, v15, ε=1.6), zinc nitride (Zn3N2, z50, ε=1.6) and zirconium nitride (ZrN, z105, ε=1.4).
  • The nitride (NI) is a nitride of an element having an electronegativity of preferably at least 1.6, and more preferably at least 1.8. In addition, the nitride (NI) is the nitride of an element having an electronegativity of preferably at most 2.2.
  • Besides, the nitride (NI) is chosen preferably from nitrides of an element chosen from Groups IIIa, IVa, IVb, Va, Vb, VIa, VIb, VIIb and VIII of the Periodic Table of the Elements, and more preferably from nitrides of an element of Group IIIa of the Periodic Table of the Elements.
  • The most preferred nitride (NI) is boron nitride.
  • The Applicant has surprisingly found that the presence of the nitride (NI), as described above, is effective in enhancing the stiffness of the composition (C) while maintaining the ductility of the unmodified PAEK polymer used thus far, thereby offering said composition (C) of the invention superior properties which allows them to be very useful as being comprised in parts of the prosthetic devices.
  • The Applicant has found that the average particle size of the nitride (NI) may play a role in improving mechanical properties such as in particular the stiffness and the tensile elongation at break of the composition (C) and in improving the aesthetics aspects, especially in improved the color of the composition (C).
  • The average particle size of the nitride (NI) is advantageously equal to or below 30 µm, preferably equal to or below 20 µm, more preferably equal to or below 18 µm, more preferably equal to or below 10 µm.
  • The average particle size of the nitride (NI) is preferably equal to or at least 0.05 µm, equal to or at least 0.1 µm, more preferably equal to or at least 0.2 µm, equal to or at least 1 µm.
  • The average particle size of the nitride (NI) is preferably from 1 µm to 20 µm, more preferably from 2 µm to 18 µm, more preferably from 2 µm to 10 µm.
  • An average particle size of the nitride (NI) of about 2.5 µm gave particularly good results.
  • The average particle size of the nitride (NI) is measured via light scattering techniques (dynamic or laser) using the respective equipment coming for example from the company Malvern (Mastersizer Micro or 3000) or using screen analysis according to DIN 53196.
  • Composition (C)
  • The composition (C) of the present invention advantageously comprises the nitride (NI) in an amount of at least 1.0 % wt, preferably at least 1.10 % wt, more preferably at least 2.0 % wt, most preferably at least 5.0 % wt based on the total weight of the composition (C).
  • As such, there is no upper limit on the amount of the nitride (NI) present in the composition (C) of the present invention.
  • In one embodiment, the composition (C) of the present invention advantageously comprises the nitride (NI) in an amount of at most 50.0 % wt, preferably at most 40.0 % wt, more preferably at most 30.0 % wt, even more preferably at most 20.0 % wt, still more preferably at most 15.0 % wt, and most preferably at most 10.0 % wt, based on the total weight of the composition (C).
  • The composition (C) of the present invention advantageously comprises the nitride (NI) in an amount ranging from 2 to 50 % wt, more preferably from 5 to 20 % wt, even more preferably from 5 to 10 % wt, based on the total weight of the composition (C).
  • The total weight of the the (PAEK) polymer, based on the total weight of the composition (C), is advantageously above 50 %, preferably above 60 % ; more preferably above 70 % ; more preferably above 80 %, more preferably above 85 %.
  • If desired, the composition (C) consists of the (PAEK) polymer and the nitride (NI).
  • A preferred composition (C) of the invention thus includes a (PAEK) polymer, as above detailed, and more preferably a (PAEK) polymer comprising recurring units (RPAEK) of formula (J'-A), as above detailed and boron nitride in an amount of 5 to 15 % wt, based on the total weight of the composition (C).
  • The composition (C) of the present invention may further comprise at least one other thermoplastic polymer (polymer T).
  • Non limitative examples of polymers (T) suitable for use in composition (C) of the present invention, include for example polyarylethersulfones, polyphenylenes, polyimides, more notably polyetherimides, and polyphenylene sulfides.
  • The weight of said other polymers is advantageously below 40 % wt, preferably below 30 % wt, and more preferably below 25 % wt based on the total weight of the composition (C).
  • The composition (C) can further comprise one or more ingredients other than the (PAEK) polymer [ingredient (I), herein after].
  • Non limitative examples of ingredient (I) suitable for use in composition (C) of the present invention, are polymeric compositions, additives such as UV absorbers ; stabilizers such as light stabilizers and heat stabilizers ; antioxidants ; lubricants ; processing aids ; plasticizers ; flow modifiers ; flame retardants ; pigments such as notably titanium dioxide (TiO2) ; dyes ; colorants ; anti-static agents ; extenders ; metal deactivators ; conductivity additive such as carbon black and carbon nanofibrils and combinations comprising one or more of the foregoing additives.
  • The weight of said ingredient (I) is advantageously below 10 % wt and preferably below 5 % wt, based on the total weight of the composition (C).
  • If desired, the composition (C) comprises more than 80 wt % of the (PAEK) polymer with the proviso that the (PAEK) polymer is the only polymeric components in the composition (C) and one or more optional ingredient such as notably UV absorbers ; stabilizers such as light stabilizers and heat stabilizers ; antioxidants ; lubricants ; processing aids ; plasticizers ; flow modifiers ; flame retardants ; pigments such as notably titanium dioxide (TiO2) ; dyes ; colorants ; anti-static agents ; extenders ; metal deactivators ; conductivity additive such as carbon black and carbon nanofibrils might be present therein, without these components dramatically affecting relevant mechanical and toughness properties of the composition (C).
  • The expression 'polymeric components' is to be understood according to its usual meaning, i.e. encompassing compounds characterized by repeated linked units, having typically a molecular weight of 2 000 or more.
  • The polymer composition (C) may further comprise at least one reinforcing filler. Reinforcing fillers are well known by the skilled in the art. They are preferably selected from fibrous and particulate fillers different from the pigment as defined above. More preferably, the reinforcing filler is selected from mineral fillers (such as talc, mica, kaolin, calcium carbonate, calcium silicate, magnesium carbonate), glass fiber, carbon fibers, synthetic polymeric fiber, aramid fiber, aluminum fiber, titanium fiber, magnesium fiber, boron carbide fibers, rock wool fiber, steel fiber, wollastonite etc. Still more preferably, it is selected from mica, kaolin, calcium silicate, magnesium carbonate, glass fiber, carbon fibers and wollastonite etc.
  • Preferably, the filler is chosen from fibrous fillers. A particular class of fibrous fillers consists of whiskers, i.e. single crystal fibers made from various raw materials, such as Al2O3, SiC, BC, Fe and Ni.
  • In one embodiment of the present invention the reinforcing filler is chosen from wollastonite and glass fiber. Among fibrous fillers, glass fibers are preferred ; they include chopped strand A-, E-, C-, D-, S-, T- and R-glass fibers, as described in chapter 5.2.3, p. 43-48 of Additives for Plastics Handbook, 2nd edition, John Murphy.
  • Glass fibers optionally comprised in polymer composition (C) may have a circular cross-section or a non-circular cross-section (such as an oval or rectangular cross-section).
  • When the glass fibers used have a circular cross-section, they preferably have an average glass fiber diameter of 3 to 30 µm and particularly preferred of 5 to 12 µm. Different sorts of glass fibers with a circular cross-section are available on the market depending on the type of the glass they are made of. One may notably cite glass fibers made from E- or S-glass.
  • Good results were obtained with standard E-glass material with a non-circular cross section. Excellent results were obtained when the polymer composition with S-glass fibers with a round cross-section and, in particular, when using round cross-section with a 6 µm diameter (E-Glass or S-glass).
  • In another embodiment of the present invention the reinforcing filler is a carbon fiber.
  • As used herein, the term "carbon fiber" is intended to include graphitized, partially graphitized and ungraphitized carbon reinforcing fibers or a mixture thereof. Carbon fibers useful for the present invention can advantageously be obtained by heat treatment and pyrolysis of different polymer precursors such as, for example, rayon, polyacrylonitrile (PAN), aromatic polyamide or phenolic resin ; carbon fibers useful for the present invention may also be obtained from pitchy materials. The term "graphite fiber" intends to denote carbon fibers obtained by high temperature pyrolysis (over 2000°C) of carbon fibers, wherein the carbon atoms place in a way similar to the graphite structure. Carbon fibers useful for the present invention are preferably chosen from the group composed of PAN-based carbon fibers, pitch based carbon fibers, graphite fibers, and mixtures thereof.
  • The weight of said reinforcing filler is advantageously preferably below 60 % wt, more preferably below 50 % wt, even more preferably below 45 % wt, most preferably below 35 % wt, based on the total weight of the composition (C).
  • Preferably, the reinforcing filler is present in an amount ranging from 10 to 60 % wt, preferably from 20 to 50 % wt, preferably from 25 to 45 % wt, most preferably from 25 to 35 % wt, based on the total weight of the polymer composition (C).
  • The composition (C) can be prepared by a variety of methods involving intimate admixing of the polymer materials with any optional ingredient, as detailed above, desired in the formulation, for example by melt mixing or a combination of dry blending and melt mixing. Typically, the dry blending of the (PAEK) polymer and the nitride (NI), and optionally the polymers (T), optionally the reinforcing filler and optionally ingredient (I), as above details, is carried out by using high intensity mixers, such as notably Henschel-type mixers and ribbon mixers.
  • So obtained powder mixture can comprise the (PAEK) polymer and the nitride (NI), and optionally the polymers (T), optionally the reinforcing filler and optionally ingredient (I), in the weight ratios as above detailed, suitable for obtaining effective formation of the above described parts of a prosthetic device, or can be a concentrated mixture to be used as masterbatch and diluted in further amounts of the (PAEK) polymer and the nitride (NI), and optionally the polymers (T), optionally the reinforcing filler and optionally ingredient (I) in subsequent processing steps.
  • It is also possible to manufacture the composition of the invention by further melt compounding the powder mixture as above described. As said, melt compounding can be effected on the powder mixture as above detailed, or preferably directly on the (PAEK) polymer and the nitride (NI), and optionally the polymers (T), optionally the reinforcing filler and optionally ingredient (I). Conventional melt compounding devices, such as co-rotating and counterrotating extruders, single screw extruders, co-kneaders, disc-pack processors and various other types of extrusion equipment can be used. Preferably, extruders, more preferably twin screw extruders can be used.
  • If desired, the design of the compounding screw, e.g. flight pitch and width, clearance, length as well as operating conditions will be advantageously chosen so that sufficient heat and mechanical energy is provided to advantageously fully melt the powder mixture or the ingredients as above detailed and advantageously obtain a homogeneous distribution of the different ingredients. Provided that optimum mixing is achieved between the bulk polymer and filler contents. It is advantageously possible to obtain strand extrudates which are not ductile of the composition (C) of the invention. Such strand extrudates can be chopped by means e.g. of a rotating cutting knife after some cooling time on a conveyer with water spray. Thus, for example composition (C) which may be present in the form of pellets or beads can then be further used for the manufacture of the above described part of a prosthetic device.
  • Another objective of the present invention is to provide a method for the manufacture of the above described part of a prosthetic device device. Such method is not specifically limited. The polymer composition (C) may be generally processed by injection molding, extrusion or other shaping technologies.
  • In one embodiment of the present invention, the method for the manufacture of the above described part of a mobile electronic device includes the step of injection molding and solidification of the polymer composition (C).
  • In another embodiment of the present invention, the method for the manufacture of the above described part of a prosthetic device includes the machining of a standard shaped structural part in a part having any type of size and shape. Non limiting examples of said standard shaped structural part include notably a plate, a rod, a slab and the like. Said standard shaped structural parts can be obtained by extrusion or injection molding of the polymer composition (C).
  • Another object of the invention is a part of a prosthetic device comprising the polymer composition as above described.
  • The Applicant has found unexpectedly that the composition (C) of the present invention is effective in providing prosthetic device parts having higher stiffness than devices of the prior art while at the same time not sacrificing the ductility, elongation, toughness and impact resistance properties of the unmodified PAEK resin that has been used thus far. Impact resistance is particularly important in prosthetic applications because in many cases the surgeon has to hammer the part into position.
  • The Applicant has also found that said prosthetic device parts comprising the composition (C) of the present invention have improved aesthetics, in particular improved lighter color and said prosthetic device parts have a higher acceptance for many applications where color is a concern, as notably in dental applications, and other cosmetic applications.
  • The prosthetic device parts of the present invention have advantageously the following color characteristics :
    • Color L* > 70, preferably L* > 71 ;
    • Color b* is at least 8
    where the color was measured on injection moulded color plaques that are 2.5 mm in thickness using the CIE Lab standards, as follows. The color is generally characterized by L*, a*, b* values, which are tristimulus coordinates defined by the CIE (Commission Internationale de l'Eclairage) in 1976 (K. Nassau, in "Kirk-Othmer Encylopedia of Chemical Technology", 2004, Chapter 7, P 303-341). These three basic coordinates represent the lightness of the color (L*, L* = 0 yields black and L* = 100 indicates white), its position between red/magenta and green (a*, negative values indicate green while positive values indicate magenta) and its position between yellow and blue (b*, negative values indicate blue and positive values indicate yellow).
  • Should the disclosure of any patents, patent applications, and publications which are incorporated herein by reference conflict with the description of the present application to the extent that it may render a term unclear, the present description shall take precedence.
  • The invention will be now described in more details with reference to the following examples, whose purpose is merely illustrative and not intended to limit the scope of the inventior.
  • Raw materials
  • KetaSpire® PEEK KT-820P is polyetheretherketone polymer commercially available from Solvay Specialty Polymers USA, LLC.
  • Boron Nitride, Boronid® S1-SF commercially available from ESK Ceramics, GmbH, average particle size of 2.5 µm.
  • Boron Nitride, Boronid® S15 commercially available from ESK Ceramics, GmbH, average particle size of 15 µm.
  • Carbon Fiber, Sigrafil C30 APS 006 from SGL Corporation Talc, Mistron Vapor R, commercially available from Luzenac America
  • General description of the compounding process of PEEK resins
  • A dry blend of PEEK resins with the desired amounts of Boronid® S1-SF or Boronid® S15 were prepared by first tumble blending for about 20 minutes, followed by melt compounding using an 25 mm Berstorff co-rotating partially intermeshing twin screw extruder having an L/D ratio of 40:1. The extruder had 8 barrel sections with barrel sections 2 through 8 being heated sections. Vacuum venting was applied at barrel section 7 with 18-20 in of vacuum during compounding to strip off moisture and any possible residual volatiles from the compound. The compounding temperature profile was such that barrel sections 2-5 were set at 330°C while barrel sections 5-8 and the die adapter were set at 340°C. The screw speed used 180 throughout and the throughput rate was 15-17 lb/hr, whereas the melt temperature, measured manually for each formulation molten extrudate, at the exit of the extruder die ranged from 398 to 402°C. The extrudate for each formulation was cooled in a water trough and then pelletized using a pelletizer. The thus obtained pellets of the four blends were next dried for 4 hours in a desiccated air oven at 150°C and subjected to mechanical testing. Said pellets were injection-molded to produce ASTM test specimens using a Toshiba 150 ton injection molding machine following standard conditions and guidelines for KetaSpire KT-820 PEEK resin provided by the supplier Solvay Specialty Polymers.
  • Mechanical properties were tested for all the formulations using injection molded 0.125 inch thick ASTM test specimens which consisted of 1) Type I tensile bars, 2) 5 in x 0.5 in x 0.125 in flexural bars, and 3) 4 in x 4 in x 0.125 in plaques for the instrumented impact (Dynatup) testing.
  • The following ASTM test methods were employed in evaluating all nine compositions :
    • D638 : Tensile properties using a test speed of 2 in/min
    • D790 : Flexural properties
    • D256 : Izod impact resistance (notched)
    • D4812 : Izod impact resistance (unnotched)
    • D3763 : Instrumented impact resistance also known by the name Dynatup impact
    • D648 : Heat deflection temperature (HDT)
    • D5279 : DMA Storage Modulus at 200°C (Pa)
  • HDT was measured at an applied stress of 264 psi and using 0.125 in-thick flexural specimens annealed at 200°C for 2 hours to assure uniform crystallinity and removal of residual molded-in stresses in the parts which can otherwise compromise the accuracy of the measurement.
  • The color of 4 in x 4 in x 0.125 injection molded plaques injection molded color plaques was measured according to ASTM E308-06 using illuminant D65 (white light simulating daylight) at 10° angle (1964 CIE).
  • L*, a* and b* color coordinates were measured using a Gretag Macbeth Color Eye Ci5 Spectrophotometer, with tribeam diffuse/8 "6" sphere optical geometry, a bandpass of 10 nm, a spectral range of 360 nm to 750 nm per CIE Lab standards using illuminant D65 and a 10 degree observer. Thus, the L, a and b color coordinates measured by this test correspond to the lightness scale (L), green-red hue scale (a) and the blue-yellow hue scale (b).
  • Composition, mechanical properties, color properties and physical properties of the nine compositions are summarized in Table 1. Table 1
    Examples Comp. example 1 (C1) 2 3 4 5 6 7 8 9
    KetaSpire KT-820P PEEK (wt %) 100.0 99.5 98.8 97.5 95.0 92.5 90.0 95.0 90.0
    Boron Nitride, Boronid® S1-SF (wt %) - 0.5 1.2 2.5 5.0 7.5 10.0
    Boron Nitride, Boronid® S15 (wt %) 5.0 10.0
    Mechanical properties
    Tensile Yield Strength (psi) 13555 13600 13700 13715 13610 13630 13640 13550 13600
    Tensile Modulus (Ksi) 536 558 580 611 679 759 839 675 830
    Tensile Yield Elongation (%) 5.1 5.0 4.9 5.0 4.9 4.80 4.7 4.9 4.7
    Tensile Elongation at Break (%) 24 35 31 33 40 46 41 23 23
    Flexural Strength (psi) 20675 21000 21300 21675 21320 22310 22860
    Flexural Modulus (Ksi) 532 558 573 601 625 710 775
    Notched Izod (ft-lb/in) 1.77 1.51 1.45 1.77 2.15 2.12 2.07 1.83 1.79
    No Notch Izod (ft-lb/in) NB NB NB NB NB NB NB NB NB
    Dynatup - Total Energy (ft-lb) 52.0 57.7 55.6 53.5 51.5 53.7 50.6 51.0 38.4
    Dynatup - Max. Load (lb) 1426 - - 1499 1513 1547 1640 1627 1478
    Dynatup - Energy at Max Load (ft-lb) 39.0 - - 41.1 40.1 42.8 44.0 45.0 36.0
    Dynatup - Max. Deflection (in) 0.64 - - 0.64 0.62 0.64 0.62 0.64 0.56
    Color properties
    CIE Lab L* Color Value 65.2 68.9 71.1 73.0 76.1 78.3 79.6 70.5 73.3
    CIE Lab a* Color Value 1.76 1.74 1.40 1.38 1.27 1.11 0.98 1.82 1.52
    CIE Lab b* Color Value 7.07 7.45 8.58 9.95 10.76 11.02 11.15 11.13 12.09
    Physical properties
    DMA Storage Modulus at 200°C (Pa) 1.30 E8 - - 1.80 E8 2.11 E8 2.65 E8 1.81 E8 2.46 E8 .1.80 E8
    HDT [Annealed 200°C/2h] (°C) 158°C - - 162°C 163°C 165°C 161°C 167°C 162°C
    NB = No break
  • General description of the compounding process of carbon fiber reinforced PEEK resins
  • Carbon fiber-reinforced PEEK formulations described in Table 2 were prepared by melt compounding using a twin screw co-rotating intermeshing extruder equipped with 8 barrel sections and an overall L/D ratio of 40. The PEEK powder was tumble blended with either the boron nitride or fed as is (in the case of the Control) in the feed hopper of the extruder. The carbon fiber was fed gravimetrically at the required proportion and was metered at a feed port on barrel section 5 of the extruder. A vacuum vent port at barrel section 7 was used to pull high vacuum on the melt to remove any residual moisture or organic volatiles that may evolve from the sizing of the carbon fiber. The compounded formulations were stranded using a one-hole 3 mm diameter and were cooled on a conveyor belt with a water spray before being fed to a pelletizer to chop the extrudate into pellets. Details of the compounding conditions are shown in Table 3. Table 2
    Properties of carbon fiber reinforced PEEK modified with talc and with boron nitride
    Examples Comparative Example 10 (C10) 11 Comparative Example 12 (C12)
    KetaSpire KT-820P PEEK 70.0 68.6 68.6
    Boron Nitride, Boronid® S1-SF - 2.0 -
    Talc, Mistron Vapor R - - 2.0
    Carbon Fiber, SGL C30 APS 006 30.0 29.4 29.4
    Mechanical properties
    Tensile Strength (psi) @0.2"/min 32050 31410 30920
    Tensile Modulus (Ksi) 3413 3470 3407
    Tensile Elongation at Break (%) 2.17 2.32 2.24
    Flex Strength (psi) 50290 49310 48970
    Flex Modulus (Ksi) 2684 2729 2689
    Flex Strain at Break (%) 2.58 2.61 2.56
    Notched Izod (ft-lb/in) 1.76 1.63 1.55
    No Notch Izod (ft-lb/in) 15.5 16.1 15.9
    Table 3
    Compounding conditions and process parameters used to make formulations listed in Table 3.
    Examples Comparative Example 10 (C10) 11 Comparative Example 12 (C12)
    Barrel Zone Temperature (°C)
    Barrel Section 1 No Heat No Heat No Heat
    Barrel Section 2 (Set Point/Actual) 330/329 330/330 330/329
    Barrel Section 3 (Set Point/Actual) 330/330 330/330 330/330
    Barrel Section 4 (Set Point/Actual) 330/331 330/330 330/331
    Barrel Section 5 (Set Point/Actual) 330/ 334 330/ 332 330/ 332
    Barrel Section 6 (Set Point/Actual) 340/ 343 340/342 340/341
    Barrel Section 7 (Set Point/Actual) 340/342 340/342 340/340
    Barrel Section 8 (Set Point/Actual) 340/340 340/342 340/341
    Adapter (Set Point/Actual) 340/340 340/341 340/ 341
    Die (Set Point/Actual) 340/340 340/341 340/341
    Actual Melt Temperature (°C) 402 407 423
    Screw Speed (rpm) 230 230 235
    Vent Vacuum on BBL Section 7 (in Hg) 29 29 29
    Feed Rate, Main (lb/hr) 7.0 7.06 7.06
    Feed Rate, Carbon Fiber (lb/hr) 3.0 2.94 2.94
    Feed Rate, Total (lb/hr) 10.0 10.0 10.0

Claims (14)

  1. A prosthetic device comprising at least one part made of a polymer composition [composition (C), herein after] comprising
    (i) at least one polyaryletherketone polymer [(PAEK) polymer],
    (ii) at least one nitride (NI) of an element having an electronegativity (ε) of from 1.3 to 2.5, as defined in « Handbook of Chemistry and Physics », CRC Press, 64th edition, pages B-65 to B-158.
  2. The prosthetic device according to claim 1, wherein more than 50 % moles of recurring units of (PAEK) polymer are recurring units (RPAEK) selected from those of formulae (J-A) to (J-O), herein below :
    Figure imgb0031
    Figure imgb0032
    Figure imgb0033
    Figure imgb0034
    Figure imgb0035
    Figure imgb0036
    Figure imgb0037
    Figure imgb0038
    Figure imgb0039
    Figure imgb0040
    Figure imgb0041
    Figure imgb0042
    Figure imgb0043
    Figure imgb0044
    Figure imgb0045
    wherein :
    - each of R', equal to or different from each other, is selected from the group consisting of halogen, alkyl, alkenyl, alkynyl, aryl, ether, thioether, carboxylic acid, ester, amide, imide, alkali or alkaline earth metal sulfonate, alkyl sulfonate, alkali or alkaline earth metal phosphonate, alkyl phosphonate, amine and quaternary ammonium ;
    - j' is zero or is an integer from 0 to 4.
  3. The prosthetic device according to any one of claims 1 or 2, wherein more than 50 % moles of recurring units of the (PAEK)polymer are recurring units (RPAEK) selected from those of formulae (J'-A) to (J'-O) herein below :
    Figure imgb0046
    Figure imgb0047
    Figure imgb0048
    Figure imgb0049
    Figure imgb0050
    Figure imgb0051
    Figure imgb0052
    Figure imgb0053
    Figure imgb0054
    Figure imgb0055
    Figure imgb0056
    Figure imgb0057
    Figure imgb0058
    Figure imgb0059
    Figure imgb0060
  4. The prosthetic device according to any one of claims 1 to 3, wherein the nitride (NI) is a nitride of an element having an electronegativity of at least 1.6.
  5. The prosthetic device according to any one of claims 1 to 4, wherein the nitride (NI) is boron nitride.
  6. The prosthetic device according to any one of claims 1 to 5, wherein the nitride (NI) is present in an amount of at most 50.0 % wt, based on the total weight of the composition (C).
  7. The prosthetic device according to anyone of claims 1 to 6, wherein the polymer composition (C) further comprises at least one other thermoplastic polymer (polymer T), different from the (PAEK) polymer.
  8. The prosthetic device according to anyone of claims 1 to 7, wherein the polymer composition (C) further comprises one or more ingredients other than the (PAEK) polymer [ingredient (I)].
  9. The prosthetic device according to anyone of claims 1 to 8, wherein the polymer composition (C) further comprises at least one reinforcing filler.
  10. The prosthetic device according to claim 9, wherein the reinforcing filler is chosen from wollastonite and glass fiber.
  11. The prosthetic device according to claim 9, wherein the reinforcing filler is a carbon fiber.
  12. The prosthetic device according to anyone of claims 1 to 11, wherein it is selected from ligaments, tendons, cartilage, bones, hip joints, knee prosthesis and spinal disc orthoprosthesis.
  13. Method for the manufacture of the part of the prosthetic device according to anyone of the claims 1 to 12, comprising a step of injection molding and solidification of the polymer composition (C).
  14. A part of a prosthetic device according to anyone of the claims 1 to 13.
EP13818212.6A 2012-12-20 2013-12-18 Prosthetic device Not-in-force EP2935461B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP13818212.6A EP2935461B1 (en) 2012-12-20 2013-12-18 Prosthetic device

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261740292P 2012-12-20 2012-12-20
EP13154978 2013-02-12
PCT/EP2013/077177 WO2014096058A1 (en) 2012-12-20 2013-12-18 Prosthetic device
EP13818212.6A EP2935461B1 (en) 2012-12-20 2013-12-18 Prosthetic device

Publications (2)

Publication Number Publication Date
EP2935461A1 EP2935461A1 (en) 2015-10-28
EP2935461B1 true EP2935461B1 (en) 2016-09-21

Family

ID=47683630

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13818212.6A Not-in-force EP2935461B1 (en) 2012-12-20 2013-12-18 Prosthetic device

Country Status (5)

Country Link
US (1) US20150306279A1 (en)
EP (1) EP2935461B1 (en)
JP (1) JP2016506263A (en)
CN (1) CN104870564A (en)
WO (1) WO2014096058A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10864295B2 (en) * 2015-05-19 2020-12-15 Shpp Global Technologies B.V. Polymeric spinal fusion system including spinal cage
CN108882944A (en) * 2016-02-29 2018-11-23 沙特基础工业全球技术公司 System and method for manufacturing customization surgical instruments
JP2018095694A (en) * 2016-12-09 2018-06-21 株式会社トクヤマデンタル Polyaryletherketone resin material for use in dentistry
EP4023703A1 (en) * 2020-12-29 2022-07-06 Arkema France Composite article made of composition(s) based on paek(s)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3071116D1 (en) 1979-06-26 1985-10-31 Ici Plc Cementitious product
GB8418088D0 (en) * 1984-02-09 1984-08-22 Ici Plc Polymer composition
US4654263A (en) * 1984-02-09 1987-03-31 Imperial Chemical Industries, Plc Polymer composition
GB8415265D0 (en) 1984-06-15 1984-07-18 Ici Plc Device
CN1267158C (en) * 2004-06-24 2006-08-02 上海交通大学 Polyetheretherketone total hip femoral head prosthesis material and preparation method thereof
US20070111165A1 (en) 2005-05-26 2007-05-17 Michael Wallick Polymer Core Prosthetic Dental Device with an Esthetic Surface
US8221462B2 (en) * 2005-08-01 2012-07-17 Globus Medical, Inc. Interspinous internal fixation/distraction device
US9232968B2 (en) * 2007-12-19 2016-01-12 DePuy Synthes Products, Inc. Polymeric pedicle rods and methods of manufacturing
GB201001830D0 (en) * 2010-02-04 2010-03-24 Finsbury Dev Ltd Prosthesis
CN102834070B (en) * 2010-03-24 2016-04-13 王茜 A kind of method grinding connector assembly
CN102028971A (en) * 2010-12-29 2011-04-27 安徽理工大学 Biological fixation type bionic joint and preparation method thereof

Also Published As

Publication number Publication date
WO2014096058A1 (en) 2014-06-26
EP2935461A1 (en) 2015-10-28
CN104870564A (en) 2015-08-26
JP2016506263A (en) 2016-03-03
US20150306279A1 (en) 2015-10-29

Similar Documents

Publication Publication Date Title
US9539361B2 (en) Prosthetic devices
EP2935461B1 (en) Prosthetic device
Wang Developing bioactive composite materials for tissue replacement
US20210129396A1 (en) Components incorporating bioactive material
CN110312752B (en) Poly (ether ketone) polymers, corresponding methods of synthesis and polymer compositions, and articles made therefrom
WO2018115033A1 (en) Poly(ether ketone ketone) polymers, corresponding synthesis methods and polymer compositions and articles made therefrom
US11780962B2 (en) Poly(ether ketone ketone) polymers, corresponding synthesis methods and polymer compositions and articles made therefrom
JP5514116B2 (en) Gamma-ray disinfectant, reinforced polymer composition with improved color stability
US11879036B2 (en) Poly(ether ketone ketone) (PEKK) polymer and composites
CA2758605A1 (en) Polymeric materials comprising barium sulphate
CN108778354A (en) Nano-engineered biologically absorbable polymer composite material for bone-soft tissue stationary applications
US20210008252A1 (en) Thermoplastic materials incorporating bioactive inorganic additives
US20150366677A1 (en) Impact resistant medical instruments, implants and methods
Joseph et al. Effect of morphological features and surface area of hydroxyapatite on the fatigue behavior of hydroxyapatite− polyethylene composites
US20180147033A1 (en) Polyaryletherketone dental block for cad/cam milling
Harsha et al. Literature review on “Peek” dental implants
WO2018115035A1 (en) Poly(ether ketone ketone) polymers, corresponding synthesis methods and polymer compositions and articles made therefrom
CN113166396B (en) Poly (ether ketone) (PEKK) polymer and composite material
Tasdemir et al. Hydroxyapatite reinforced polypropylene bio composites
JP2014108296A (en) Biodegradable and absorbent fiber-reinforced composite material and method for producing the same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150720

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20160422

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 831031

Country of ref document: AT

Kind code of ref document: T

Effective date: 20161015

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602013012018

Country of ref document: DE

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 4

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161221

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20161110

Year of fee payment: 4

Ref country code: DE

Payment date: 20161213

Year of fee payment: 4

Ref country code: FR

Payment date: 20161111

Year of fee payment: 4

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 831031

Country of ref document: AT

Kind code of ref document: T

Effective date: 20160921

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161222

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170121

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170123

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161221

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602013012018

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

26N No opposition filed

Effective date: 20170622

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161218

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161231

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161218

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20131218

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602013012018

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MM

Effective date: 20180101

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20171218

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161218

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180101

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20180831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180703

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160921

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180102

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171218